US 10,300,050 B2Granted

Succinate salt of cytisine and use thereof

AssigneeAchieve Pharma UK Limited

InventorsAnthony Clarke, Richard Allistair Stewart, Andrew Gareth Willis

Life of this patent

Estimating the term…

Abstract

The invention relates to a novel salt of cytisine and pharmaceutical compositions comprising that salt. In particular, the invention relates to a succinate salt of cytisine which displays improved excipient compatibility, permitting the preparation of stable pharmaceutical compositions.

Claims16

Dependent claims

A succinate salt of cytisine.

Dependencies are inferred from the claim text.

Facts

Application: 16/075,902Filed 6 Feb 2017
Priority: GB 1602145.35 Feb 2016
Published: US 2019/0038608 A17 Feb 2019
Granted: 28 May 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 31/439
Having six-membered rings with one nitrogen as the only ring hetero atom: the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/2059
Polysaccharides, e.g. alginate, gums; Cyclodextrin: starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
A61K 9/48
Medicinal preparations characterised by special physical form: preparations in capsules, e.g. of gelatin, of chocolate

Family

US 2019/0038608 A1Pre-grant publication · published 7 Feb 2019
US 10,300,050 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results